Tivicay

FDA approves dispersible tablet formulation of dolutegravir for HIV in children
FDA approves dispersible tablet formulation of dolutegravir for HIV in children
Pharmaceutical Business Review
ViiV Healthcare
FDA
Tivicay
pediatric
Flag link:
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Top GSK/ViiV scientist who co-invented an HIV blockbuster books a trip to biotech
Endpoints
GSK
ViiV
Tivicay
HIV
HemoShear
Flag link:
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
4 Biggest HIV Drugs of 2024: Which Stocks Are Poised to Profit?
Motley Fool
HIV
Gilead Sciences
Biktarvy
GSK
Triumeq
Genvoya
Tivicay
Flag link:
GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth
GlaxoSmithKline's next-generation HIV battle against Gilead is already taking a toll on growth
Fierce Pharma
GSK
HIV
Biktarvy
Gilead Sciences
Triumeq
Tivicay
Flag link:
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Yahoo/Zacks.com
GSK
Triumeq
Tivicay
Anoro
Incruse
Menveo
Bexsero
Shingrix
Nucala
Flag link:
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
GlaxoSmithKline gambles against Gilead with risky bet on two-drug HIV combos
Fierce Pharma
GSK
Gilead Sciences
HIV
Tivicay
Edurant
Janssen
ViiV
Flag link:
GSK's modern HIV drug to be rolled out in Botswana
GSK's modern HIV drug to be rolled out in Botswana
Yahoo/Reuters
GSK
HIV
Tivicay
Botswana
Africa
Flag link:
Viiv Healthcare expands access to HIV drug through patent pooling
Viiv Healthcare expands access to HIV drug through patent pooling
BioPharma Dive
ViiV Healthcare
HIV
patent pooling
Tivicay
Flag link:
A Pivotal Moment For GlaxoSmithKline
A Pivotal Moment For GlaxoSmithKline
Seeking Alpha
GSK
Tivicay
Flag link:
Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land
Bring out the confetti: 7 of 2013's launches will join Sovaldi, Tecfidera in blockbuster land
Fierce Pharma Marketing
drug launches
Tecfidera
Sovaldi
Aubagio
Imbruvica
Tivicay
Breo Ellipta and Anoro Ellipta
Kadcyla
Invokana
Pomolyst
Flag link:
Glaxo, Pfizer's HIV Treatment Recommended by EU Regulator
Glaxo, Pfizer's HIV Treatment Recommended by EU Regulator
Bloomberg
GSK
Pfizer
HIV
Europe
Tivicay
Flag link:
Glaxo Seeks EU Approval for HIV Drug
Glaxo Seeks EU Approval for HIV Drug
Yahoo/Zacks
GSK
Europe
HIV
Tivicay
ViiV Healthcare
abacavir
lamivudine
Flag link:
Can This HIV Drug Challenge Gilead's Domination?
Can This HIV Drug Challenge Gilead's Domination?
Motley Fool
Gilead
HIV
ViiV Healthcare
Tivicay
GSK
Shionogi
Pfizer
Flag link:
Glaxo's Tivicay Gets Approval
Glaxo's Tivicay Gets Approval
Yahoo/Zacks
HIV
GSK
Tivicay
Flag link:
FDA Delivers a Double Dose of Good News in the Fight Against HIV
FDA Delivers a Double Dose of Good News in the Fight Against HIV
Motley Fool
FDA
HIV
Alere
Alere Determine
Tivicay
vaccines
ViiV Healthcare
GSK
Shionogi
Pfizer
Flag link:
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Glaxo Wins U.S. FDA Approval for New Daily HIV Therapy
Bloomberg
GSK
FDA
HIV
ViiV Healthcare
Tivicay
Dolutegravir
Flag link: